Healthcare provider profile · identity verified

Damacio Pagan Rodriguez, MD

General Practice · ORLANDO, FL · NPI 1811965890

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	374	139
Atorvastatin Calcium	Atorvastatin Calcium	367	186
Losartan Potassium	Losartan Potassium	318	127
Metformin Hcl	Metformin Hcl	254	112
Ibuprofen	Ibuprofen	250	97
Baclofen	Baclofen	218	74
Lisinopril	Lisinopril	209	96
Gabapentin	Gabapentin	179	77
Pantoprazole Sodium	Pantoprazole Sodium	138	56
Glipizide	Glipizide	132	61
Amlodipine Besylate	Amlodipine Besylate	131	63
Montelukast Sodium	Montelukast Sodium	129	55
Metoprolol Tartrate	Metoprolol Tartrate	128	48
Famotidine	Famotidine	114	54
Tizanidine Hcl	Tizanidine Hcl	106	41
Prednisone	Prednisone	102	70
Hydrochlorothiazide	Hydrochlorothiazide	95	38
Levothyroxine Sodium	Levothyroxine Sodium	94	38
Tamsulosin Hcl	Tamsulosin Hcl	94	39
Albuterol Sulfate Hfa	Albuterol Sulfate	89	29
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	85	29
Meloxicam	Meloxicam	81	38
Trazodone Hcl	Trazodone Hcl	74	34
Simvastatin	Simvastatin	63	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	26
Alendronate Sodium	Alendronate Sodium	60	28
Tramadol Hcl	Tramadol Hcl	57	12
Fluticasone Propionate	Fluticasone Propionate	56	20
Advair Hfa	Fluticasone Propion/Salmeterol	55	16
Gemfibrozil	Gemfibrozil	53	24
Glimepiride	Glimepiride	46	20
Lantus	Insulin Glargine,hum.Rec.Anlog	45	19
Sertraline Hcl	Sertraline Hcl	45	18
Ketoconazole	Ketoconazole	44	11
Azithromycin	Azithromycin	42	39
Clopidogrel	Clopidogrel Bisulfate	42	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	35
Oxybutynin Chloride	Oxybutynin Chloride	38	16
Triamcinolone Acetonide	Triamcinolone Acetonide	38	14
Vitamin D2	Ergocalciferol (Vitamin D2)	37	20
Azelastine Hcl	Azelastine Hcl	36	13
Folic Acid	Folic Acid	36	18
Omeprazole	Omeprazole	35	15
Temazepam	Temazepam	34	suppressed
Finasteride	Finasteride	33	14
Buspirone Hcl	Buspirone Hcl	32	15
Allopurinol	Allopurinol	31	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Meclizine Hcl	Meclizine Hcl	30	17
Alprazolam	Alprazolam	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	13
Carvedilol	Carvedilol	26	14
Donepezil Hcl	Donepezil Hcl	25	15
Escitalopram Oxalate	Escitalopram Oxalate	25	12
Lorazepam	Lorazepam	25	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	22	suppressed
Lactulose	Lactulose	22	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Cromolyn Sodium	Cromolyn Sodium	19	suppressed
Atenolol	Atenolol	18	suppressed
Naproxen	Naproxen	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Calcitriol	Calcitriol	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Cyproheptadine Hcl	Cyproheptadine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	16	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Furosemide	Furosemide	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Torsemide	Torsemide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Cefadroxil	Cefadroxil	12	11
Enbrel Sureclick	Etanercept	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error